G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/24/2002	WO2002084276A1 Separation devices and methods for separating particles
10/24/2002	WO2002084266A2 Biological measurement system
10/24/2002	WO2002084262A2 Processes for evaluating agricultural and/or food materials; applications; and, products
10/24/2002	WO2002084261A2 Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy
10/24/2002	WO2002084260A1 Method and device for controlling the quality and/or optically characterizing milk
10/24/2002	WO2002084254A1 Method and micro-press for characterising mechanical properties of pharmaceutical solids
10/24/2002	WO2002084252A2 Epitope-captured antibody display
10/24/2002	WO2002084251A2 Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture
10/24/2002	WO2002084250A2 Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083955A1 Methods and compositions for nucleotide analysis
10/24/2002	WO2002083954A1 Mobility-modified nucleobase polymers and methods of using same
10/24/2002	WO2002083953A1 Methods for identifying small molecules that bind specific rna structural motifs
10/24/2002	WO2002083951A1 Multiplexed ligand/protein binding assays with pna labels
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083949A1 A method for detecting hybridized nucleic acid with improved sensitivity
10/24/2002	WO2002083947A1 Examination method for judging treatment for cancer, reagent for the examination and method of screening remedy relating to cancer
10/24/2002	WO2002083946A1 Method of examining allergic disease
10/24/2002	WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002	WO2002083942A2 Method and device for determining and selecting molecule-molecule interactions
10/24/2002	WO2002083938A2 Screening methods for identifying ligands
10/24/2002	WO2002083937A2 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002	WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	WO2002083934A1 P2yac receptor involved in platelet aggregation
10/24/2002	WO2002083929A2 System and method for quantitating transcription factors
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083927A2 Universal multi-variant detection system
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083923A2 Methods for quantification and de novo polypeptide sequencing by mass spectrometry
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083918A2 Novel microarrays and methods of use thereof
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083913A1 Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083897A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002	WO2002083894A1 Linear nucleic acid sequence comprising repeats and lacking secondary structure
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083852A2 Microfermentor device and cell based screening method
10/24/2002	WO2002083848A2 Methods and apparatus for selectively processing eggs having identified characteristics
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083846A2 Methods of analysis and labeling of protein-protein interactions
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083839A2 P450 single nucleotide polymorphism biochip analysis
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083735A1 Novel receptor protein and dna thereof
10/24/2002	WO2002083731A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083708A2 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083606A1 A linker system for the synthesis and screening of combinatorial libraries of polyamine derivatives on water compatible supports
10/24/2002	WO2002083262A1 Cell separation compositions and methods
10/24/2002	WO2002083174A1 Method of administering substance to left ventricle
10/24/2002	WO2002083137A1 Use of npy y2 receptor antagonists
10/24/2002	WO2002083082A2 Composition and method for destruction of infectious prion proteins
10/24/2002	WO2002083081A2 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
10/24/2002	WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	WO2002082919A1 Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
10/24/2002	WO2002067004B1 Method and apparatus for detection and measurement of accumulations of magnetic particles
10/24/2002	WO2002066077A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002065091A3 Pin1 as marker for abnormal cell growth
10/24/2002	WO2002064618A9 Methods of identifying agents that mediate polypeptide aggregation
10/24/2002	WO2002064023A3 Fra-1 expression in brain cancer
10/24/2002	WO2002064018A3 Immortalized human familial prostatic cancer cell lines
10/24/2002	WO2002064015A8 Pin1 as a marker for prostate cancer
10/24/2002	WO2002063271A8 Activity based probe analysis
10/24/2002	WO2002061061A3 Inhibition of interleukin-1-beta secretion by card proteins
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002058714A3 Methods and agents modulating upa/upar activity
10/24/2002	WO2002046760A3 Method of immobilising molecules and particles on a hydrophobic polymer surface wherein mucin is used
10/24/2002	WO2002045570A9 Methods and compositions for the diagnosis and treatment of viral disease using 55092
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002023188A3 Apparatus and method for detecting and classifying chemicals, particles, vira, and bacteria in fluids and air
10/24/2002	WO2002022830A3 Transglutaminase gene products
10/24/2002	WO2002018952A3 Biosensor assay device and method
10/24/2002	WO2002018946A3 Immobilised phosphatidic acid probe
10/24/2002	WO2002014831A3 Inflatable mannequin and system for thermal property measurement and associated methods
10/24/2002	WO2002008744A3 Method and devices for capillary electrophoresis with a norbornene based surface coating
10/24/2002	WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002	WO2002004954A3 Early diagnosis of conformational diseases
10/24/2002	WO2002002001A3 Epithelial diagnostic aid
10/24/2002	WO2001079842A3 Method for identifying regulators of protein-age formation
10/24/2002	WO2001077375A8 Diagnosis of diseases associated with gene regulation
10/24/2002	WO2001075450A3 Fluorescent lifetime assays for non-invasive quantification of analytes
10/24/2002	WO2001068911A8 Diagnosis of diseases associated with the cell cycle
10/24/2002	WO2001062975A9 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001059114A9 Tumor suppressor gene, p47ing3

1 ... 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 ... 3937